Positron emission tomography studies of abnormal glucose metabolism in schizophrenia

Schizophrenia Bulletin

Volumn 24, Issue 3, 1998, Pages 343-364

  Buchsbaum, Monte S ^a   Hazlett, Erin A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Brain imaging; Deoxyglucose; Frontal lobe; Receptor ligands; Striatum; Thalamus

Indexed keywords

GLUCOSE;

ARTICLE; BLOOD OXYGEN TENSION; BRAIN BLOOD FLOW; BRAIN METABOLISM; CORPUS STRIATUM; DIAGNOSTIC IMAGING; FRONTAL LOBE; GLUCOSE UTILIZATION; HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCHIZOPHRENIA; THALAMUS;

EID: 0031868987     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a033331     Document Type: Article

References (164)

1. Abercrombie, H.C.; Schaefer, S.M.; Larson, C.L.; Ward, R.T.; Holden, J.E.; Turski, P.A.; Perlman, S.B.; and Davidson, R.J. Prefrontal and Amygdalar Glucose Metabolism in Depressed and Control Subjects: An FDG-PET Study. [Abstract] Presented at the Annual Meeting of the Society for Psychophysiological Research, Vancouver, BC, Canada, October 1996.
2. Alexander, G.E.; DeLong, M.R.; and Strick, P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience, 9:357-381, 1986.
3. 18F-labelled fluorodeoxyglucose and positron emission tomography. British Journal of Psychiatry, 169:509-516, 1996.
4. 2O studies of human cognition. Journal of Cerebral Blood Flow and Metabolism, 16:804-816, 1996.
5. Andreasen, N.C.; Arndt, S.; Swayze, V.; Cizadlo, T.; Flaum, M.; O'Leary, D.; Ehrhardt, J.C.; and Yuh, W.T.C. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science, 266:294-298, 1994.
6. Andreasen, N.C.; O'Leary, D.S.; Cizadlo, T.; Arndt, S.; Rezai, K.; Watkins, L.; Ponto, L.L.B.; and Hichwa, R.D. Remembering the past: Two facets of episodic memory explored with positron emission tomography. American Journal of Psychiatry, 152:1576-1585, 1995.
7. Andreasen, N.C.; O'Leary, D.S.; Flaum, M.; Nopoulos, P.; Watkins, G.L.; Boles Ponto, L.L.; and Hichwa, R.D. Hypofrontality in schizophrenia: Distributed dysfunctional circuits in neuroleptic-naive patients. Lancet, 349:1730-1734, 1997.
8. Andreasen, N.C.; Rezai, K.; Alliger, R.; Swayze, V.W.; Flaum, M.; Kirchner, P.; Cohen, G.; and O'Leary, D.S. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Archives of General Psychiatry, 49:943-958, 1992.
9. Bartlett, E.J.; Brodie, J.D.; Simkowitz, P.; Dewey, S.L.; Rusinek, H.; Volkow, N.D.; Wolf, A.P.; Smith, G.; Wolkin, A.; and Cancro, R. Time-dependent effects of a haloperidol challenge on energy metabolism in the normal human brain. Psychiatry Research, 66:91-99, 1996.
10. Bartlett, E.J.; Brodie, J.D.; Simkowitz, P.; Dewey, S.L.; Rusinek, H.; Wolf, A.P.; Fowler, J.S.; Volkow, N.D.; Smith, G.; and Wolkin, A. Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. American Journal of Psychiatry, 151:681-686, 1994.
11. Bartlett, E.J.; Brodie, J.D.; Wolf, A.P.; Christman, D.R.; Laska, E.; and Meissner, M. Reproducibility of cerebral glucose metabolic measurements in resting human subjects. Journal of Cerebral Blood Flow and Metabolism, 8:502-512, 1988.
12. Bartlett, E.J.; Wolkin, A.; Brodie, J.D.; Laska, E.M.; and Wolf, A.P. Importance of pharmacologic control in PET studies: Effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia. Psychiatry Research, 40:115-124, 1991.
13. Baxter, L.R.; Brody, A.; Saxena, S.; Schwartz, J.; and Ackermann, R. Specific brain systems in obsessive-compulsive disorder treatment. [Abstract] European Neuropsychopharmacology, 6(Suppl. 3):91, 1996.
14. Baxter, L.R.; Phelps, M.E.; Mazziotta, J.C.; Guze, B.H.; Schwartz, J.M.; and Selin, C.E. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Archives of General Psychiatry, 44:211-218, 1987.
15. Baxter, L.R.; Schwartz, J.M.; Bergman, K.S.; Szuba, M.P.; Guze, B.H.; Mazziotta, J.C.; Alzraki, A.; Selin, C.E.; Ferng, H.-K.; Munford, P.; and Phelps, M.E. Caudate glucose metabolic rate changes with both drug and behavior therapy in obsessive-compulsive disorder. Archives of General Psychiatry, 49:681-689, 1992.
16. Baxter, L.R., Jr.; Schwartz, J.M.; Phelps, M.E.; Mazziotta, J.C.; Guze, B.H.; Selin, C.E.; Gerner, R.H.; and Sumida, R.M. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Archives of General Psychiatry, 46:243-250, 1989.
17. Berman, K.F.; Ostrem, J.L.; Randolph, C.; Gold, J.; Goldberg, T.E.; Coppola, R.; Carson, R.E.; Herscovitch, P.; and Weinberger, D.R. Physiological activation of a cortical network during performance of the Wisconsin Card Sorting Test: A positron emission tomography study. Neuropsychologia, 33:1027-1046, 1995.
18. Berman, K.F.; Torrey, E.F.; Daniel, D.G.; and Weinberger, D.R. Regional cerebral blood flow in monozygotic twins discordant and concordant for schizophrenia. Archives of General Psychiatry, 49:927-934, 1992.
19. Bertollo, D.N.; Cowen, M.A.; and Levy, A.V. Hypometabolism in olfactory cortical projection areas of male patients with schizophrenia: An initial positron emission tomography study. Psychiatry Research, 60:113-116, 1996.
20. Biver, F.; Goldman, S.; De Maertelaer, V.; Luxen, A.; Mendlewicz, J.; and Lotstra, F. Interregional correlation of cerebral glucose metabolism in unmedicated schizophrenia. European Neuropsychopharmacology, 6:141-147, 1996.
21. Biver, F.; Goldman, S.; Luxen, A.; Delvenne, V.; De Maertelaer, V.; De La Fuente, J.; Mendlewicz, J.; and Lotstra, F. Altered frontostriatal relationship in unmedicated schizophrenic patients. Psychiatry Research: Neuroimaging, 61:161-171, 1995.
22. Bracha, H.S. Asymmetric rotational (circling) behavior, a dopamine-related asymmetry: Preliminary findings in unmedicated and never-medicated schizophrenic patients. Biological Psychiatry, 22:995-1003, 1987.
23. Braff, D.L.; Grillon, C.; and Geyer, M.A. Gating and habituation of the startle reflex in schizophrenic patients. Archives of General Psychiatry, 49:206-215, 1992.
24. Breier, A.; Malhotra, A.K.; Pinals, D.A.; Weisenfeld, N.I.; and Pickar, D. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. American Journal of Psychiatry, 154:805-811, 1997.
25. Buchsbaum, M.S. Self-regulation of stimulus intensity: Augmenting/reducing and the average evoked response. In: Schwartz, G.E., and Shapiro, D., eds. Consciousness and Self-Regulation: Advances in Research. Vol. 1. New York, NY: Plenum Press, 1976. pp. 101-135.
26. Buchsbaum, M.S. The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophrenia Bulletin, 16(3):379-389, 1990.
27. Buchsbaum, M.S.; Haier, R.J.; Potkin, S.G.; Nuechterlein, K.; Bracha, S.; Katz, M.; Lohr, J.; Wu, J.; Lottenberg, S.; Jerabek, P.A.; Trenary, M.; Tafalla, R.; Reynolds, C.; and Bunney, W.E., Jr. Fronto-striatal disorder of cerebral metabolism in never-medicated schizophrenics. Archives of General Psychiatry, 49:935-942, 1992a.
28. Buchsbaum, M.S., and Hazlett, E.A. Functional brain imaging and aging in schizophrenia. Schizophrenia Research, 27:129-141, 1997a.
29. Buchsbaum, M.S., and Hazlett, E.A. Update on PET glucose methodology. International Review of Psychiatry, 9:339-354, 1997b.
30. Buchsbaum, M.S.; Holcomb, H.H.; DeLisi, L.E. Cappelletti, J.; King, A.C.; Johnson, J.; Hazlett, E.A. Post, R.M.; Morihisa, J.; Carpenter, W.T., Jr.; Cohen, R.; Pickar, D.; and Kessler, R. Anteroposterior gradients in schizophrenia and affective disorders. Archives of General Psychiatry, 41:1159-1166, 1984a.
31. Buchsbaum, M.S.; Ingvar, D.H.; Kessler, R.; Waters, R.N.; Cappelletti, J.; van Kammen, D.P.; King, A.C.; Johnson, J.J.; Manning, R.G.; Flynn, R.M.; Mann, L.S.; Bunney, W.E., Jr.; and Sokoloff, L. Cerebral glucography with positron tomography in normals and in patients with schizophrenia. Archives of General Psychiatry, 39:251-259, 1982.
32. Buchsbaum, M.S.; Mirsky, A.F.; DeLisi, L.E.; Morihisa, J.; Karson, C.N.; Mendelson, W.B.; King, A.C.; Johnson, J.; and Kessler, R. The Genain quadruplets: Electrophysiological, positron emission, and X-ray tomographic studies. Psychiatry Research, 13:95-108, 1984b.
33. Buchsbaum, M.S.; Nuechterlein, K.H.; Haier, R.J.; Wu, J.; Sicotte, N.; Hazlett, E.A.; Asamow, R.; Potkin, S.; Guich, S.; and Lagunas-Solar, M. Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography. British Journal of Psychiatry, 156:216-227, 1990.
34. Buchsbaum, M.S.; Potkin, S.; Marshall, J.; Lottenberg, S.; Teng, C.; Heh, C.W.; Tafalla, R.; Reynolds, C.; Abel, L.; Plon, L.; and Bunney, W.E., Jr. Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia. Neuropsychopharmacology, 6:155-163, 1992b.
35. Buchsbaum, M.S.; Potkin, S.G.; Siegel, B.V.; Lohr, J.; Katz, M.; Gottschalk, L.A.; Gulasekaram, B.; Marshall, J.F.; Lottenberg, S.; Teng, C.Y.; Abel, L.; Plon, L.; and Bunney, W.E., Jr. Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Archives of General Psychiatry, 49:966-974, 1992c.
36. Buchsbaum, M.S.; Someya, T.; Teng, C.Y.; Abel, L.; Chin, S.; Najafi, A.; Haier, R.J.; Wu, J.; and Bunney, W.E., Jr. PET and MRI of the thalamus in never-medicated patients with schizophrenia. American Journal of Psychiatry, 153(2):191-199, 1996.
37. Buchsbaum, M.S.; Spiegel-Cohen, J.; and Wei, T. Three-dimensional PET/MRI images in OCD and schizophrenia. CNS Spectrums, 2:26-31, 1997a.
38. Buchsbaum, M.S.; Teng, C.Y.; Peled, S.; Gudbjartsson, H.; Lu, D.; Hazlett, E.A.; Downhill, J.; Haznedar, M.; Fallon, J.H.; and Atlas, S.W. MRI white matter diffusion anistropy and PET metabolic rate in schizophrenia. Neuroreport, 9:425-430, 1998.
39. Buchsbaum, M.S.; Tang, S.W.; Wu, J.C.; Hazlett, E.A.; Donoghue, D.E.; Higa, J.; and Haier, R. Effects of amoxapine and imipramine on cerebral glucose metabolism assessed by positron emission tomography. Journal of Clinical Psychiatry, 4:14-17, 1986.
40. Buchsbaum, M.S.; Trestman, R.L.; Hazlett, E.A.; Siegel, B.V., Jr.; Shaefer, C.H.; Luu-Hsia, C.; Tang, C.; Herrera, S.; Solimando, A.; Losonczy, M.; Serby, M.; Silverman, J.; and Siever, L.J. Regional cerebral blood flow during the Wisconsin Card Sort Test in schizotypal personality disorder. Schizophrenia Research, 27:21-28, 1997b.
41. Buchsbaum, M.S.; Wu, J.C.; DeLisi, L.E.; Holcomb, H.H.; Hazlett, E.; Cooper-Langston, K.; and Kessler, R. Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: Differences between normal controls and schizophrenic patients. Biological Psychiatry, 22:479-494, 1987a.
42. Buchsbaum, M.S.; Wu, J.C.; Haier, R.J.; Hazlett, E.A.; Ball, R.; Katz, M.; Sokolski, K.; Lagunas-Solar, M.; and Langer, D.H. Positron emission tomography assessment of effects of benzodiazepines on regional glucose metabolic rate in patients with anxiety disorder. Life Sciences, 40:2393-2400, 1987a.
43. Cantor-Graae, E.; Warkentin, S.; Franzén, G.; Risberg, J.; and Ingvar, D.H. Aspects of stability of regional cerebral blood flow in chronic schizophrenia: An 18-year followup study. Psychiatry Research: Neuroimaging, 40(4):253-266, 1991.
44. Cascella, N.G.; Tarazi, F.I.; Shirakawa, O.; and Tamminga, C.A. Savoxepine fails to selectively influence glucose metabolism in the rat limbic system. Psychopharmacology, 114:275-280, 1994.
45. Catafau, A.M.; Parellada, E.; Lomeña, F.J.; Bernardo, M.; Pavia, J.; Ros, D.; Setoain, J.; and Gonzalez-Monclús, E. Prefrontal and temporal blood flow in schizophrenia: Resting and activation technetium-99m-HMPAO SPECT patterns in young neuroleptic-naive patients with acute disease. Journal of Nuclear Medicine, 35:935-941, 1994.
46. Chua, S.E., and McKenna, P.J. Schizophrenia - A brain disease? A critical review of structural and functional cerebral abnormality in the disorder. British Journal of Psychiatry, 166:563-582, 1995.
47. Clark, C.M.; Carson, R.; Kessler, R.; Margolin, R.; Buchsbaum, M.S.; DeLisi, L.E.; King, A.C.; and Cohen, R. Alternate statistical models for the examination of clinical PET/FDG data. Journal of Cerebral Blood Flow, 5:142-150, 1985.
48. Clark, C.M.; Kessler, R.; Buchsbaum, M.S.; Margolin, R.A.; and Holcomb, H.H. Correlational methods for determining regional coupling of cerebral glucose metabolism: A pilot study. Biological Psychiatry, 19:663-678, 1984.
49. Clark, C.M.; Klonoff, H.; Tyhurst, J.S.; Ruth, T.; Adam, M.; Rogers, J.; Harrop, R.; Martin, W.; and Pate, B. Regional cerebral glucose metabolism in identical twins. Neuropsychologia, 26:615-621, 1988.
50. Cleghorn, J.M.; Garnett, E.S.; Nahmias, C.; Firnau, G.; Brown, G.M.; Kaplan, R.; Szechtman, H.; and Szechtman, B. Increased frontal and reduced parietal metabolism in acute untreated schizophrenia. Psychiatry Research, 28:119-133, 1989.
51. Cleghorn, J.M.; Szechtman, H.; Garnett, E.S.; Brown, G.M.; Nahmias, C.; Szechtman, B.; Kaplan, R.; and Franco, S. Neuroleptic effects on regional brain metabolism in first episode schizophrenics. Schizophrenia Research, 5:208-209, 1991a.
52. Cleghorn, J.M.; Zipursky, R.B.; and List, S.J. Structural and functional brain imaging in schizophrenia. Journal of Psychiatry and Neuroscience, 16:53-74, 1991b.
53. Cohen, R.M.; Nordahl, T.E.; Semple, W.E.; Andreason, P.; Litman, R.E.; and Pickar, D. The brain metabolic patterns of clozapine-and fluphenazine-treated patients with schizophrenia during a continuous performance task. Archives of General Psychiatry, 54:481-486, 1997.
54. Cohen, R.M.; Nordahl, T.E.; Semple, W.E.; Andreason, P.; and Pickar, D. Abnormalities in the distributed network of sustained attention predict neuroleptic treatment response in schizophrenia. Neuropsychopharmacology, 19:36-47, 1998.
55. Cohen, R.M.; Semple, W.E.; Gross, M.; Nordahl, T.E.; DeLisi, L.E.; Holcomb, H.H.; King, A.C.; Morihisa, J.M.; and Pickar, D. Dysfunction in a prefrontal substrate of sustained attention in schizophrenia. Life Sciences, 40:2031-2039, 1987.
56. Cohen, R.M.; Semple, W.E.; Gross, M.; Nordahl, T.E.; Holcomb, H.H.; Dowling, S.; and Pickar, D. The effect of neuroleptics on dysfunction in a prefrontal substrate of sustained attention in schizophrenia. Life Sciences, 43:1141-1150, 1988.
57. Cohen, R.M.; Semple, W.E.; Gross, M.; Nordahl, T.E.; King, A.C.; Pickar, D.; and Post, R.M. Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia. Neuropsychopharmacology, 2:241-254, 1989.
58. Cottraux, J.; Gérard, D.; Cinotti, L.; Froment, J.C.; Deiber, M.P.; Le Bars, D.; Galy, G.; Millet, P.; Labbé, C.; Lavenne, F.; Bouvard, M.; and Mauguière, F. A controlled positron emission tomography study of obsessive and neutral auditory stimulation in obsessive-compulsive disorder with checking rituals. Psychiatry Research, 60:101-112, 1996.
59. Crosson, B., and Hughes, C.W. Role of the thalamus in language: Is it related to thought disorder? Schizophrenia Bulletin, 13(4):605-621, 1987.
60. Deicken, R.F.; Merrin, E.L.; Floyd, T.C.; and Weiner, M.W. Correlation between left frontal phospholipids and Wisconsin Card Sort Test performance in schizophrenia. Schizophrenia Research, 14:177-181, 1995.
61. DeLisi, L.E.; Buchsbaum, M.S.; Holcomb, H.H.; Dowling-Zimmerman, S.; Pickar, D.; Boronow, J.; Morihisa, J.M.; van Kammen, D.P.; Carpenter, W.T., Jr.; Kessler, R.; and Cohen, R.M. Clinical correlates of decreased anterposterior metabolic gradients in positron emission tomography (PET) of schizophrenic patients. American Journal of Psychiatry, 142:78-81, 1985.
62. DeLisi, L.E.; Buchsbaum M.S.; Holcomb, H.H.; Langston, K.C.; King, A.C.; Kessler, R.; Pickar, D.; Carpenter, W.T., Jr.; Morihisa, J.M.; Margolin, R.; and Weinberger, D.R. Increased temporal lobe glucose use in chronic schizophrenic patients. Biological Psychiatry, 25:835-851, 1989.
63. DeLisi, L.E.; Mirsky, A.F.; Buchsbaum, M.S.; van Kammen, D.P.; Berman, K.F.; Caton, C.; Kafka, M.S.; Ninan, P.T.; Phelps, B.H.; Karoum, F.; Ko, G.N.; Korpi, E.R.; Linnoila, M.; Scheinin, M.; and Wyatt, R.J. Psychiatry Research, 13:59-76, 1984.
64. de Wit, H.; Metz, J.; Wagner, N.; and Cooper, N. Effects of diazepam on cerebral metabolism and mood in normal volunteers. Neuropsychopharmacology, 5:33-41, 1991.
65. Dolan, R.J.; Fletcher, P.; Frith, C.D.; Friston, K.J.; Frackowiak, R.S.J.; and Grasby, P.M. Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia. Nature, 378:180-182, 1995.
66. Duncan, G.E., and Stumpf, W.E. Brain activity patterns: Assessment by high resolution autoradiographic imaging of radiolabeled 2-deoxyglucose and glucose uptake. Progress in Neurobiology, 37:365-382, 1991.
67. Early, T.S.; Reiman, E.M.; Raichle, M.E.; and Spitznagel, E.L. Left globus pallidus abnormality in never-medicated patients with schizophrenia. Proceedings of the National Academy of Sciences of the United States of America, 84: 561-563, 1987.
68. Farkas, T.; Wolf, A.P.; Jaeger, J.; Brodie, J.D.; Christman, D.R.; and Fowler, J.S. Regional brain glucose metabolism in chronic schizophrenia: A positron emission transaxial tomographic study. Archives of General Psychiatry, 41:293-300, 1984.
69. Freo, U.; Holloway, H.W.; Grieg, N.H.; and Soncrant, T.T. Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin. Psychopharmacology, 107:30-38, 1992.
70. Freo, U.; Pietrini, P.; Dam, M.; Pizzolato, G.; and Battistin, L. The tricyclic antidepressant clomipramine dose-dependently reduces regional cerebral metabolic rates for glucose in awake rats. Psychopharmacology, 113:53-59, 1993.
71. Freo, U.; Rapoport, S.I.; and Soncrant, T.T. Age-related alterations in behavioral and cerebral metabolic responses to the serotonin agonist meta-chlorophenylpiperazine in rats. Neurobiology of Aging, 12:137-144, 1991a.
72. 2 receptor agonist, on local cerebral glucose metabolism in awake rats. Brain Research, 541:63-69, 1991b.
73. Friston, K.J.; Frith, C.D.; Liddle, P.F.; and Frackowiak, R.S.J. Functional connectivity: The principal-component analysis of large (PET) data sets. Journal of Cerebral Blood Flow and Metabolism, 13:5-14, 1993.
74. Friston, K.J.; Liddle, P.F.; Frith, C.D.; Hirsch, S.R.; and Frackowiak, R.S.J. The left medial temporal region and schizophrenia: A PET study. Brain, 115:367-382, 1992.
75. Fuster, J.M. The Prefrontal Cortex: Anatomy, Physiology, and Neuropsychology of the Frontal Lobe. New York, NY: Raven Press, 1989.
76. George, M.S.; Ketter, T.A.; Parekh, P.; Horwitz, B.; Herscovitch, P.; and Post, R.M. Brain activity during transient sadness and happiness in healthy women. American Journal of Psychiatry, 152:341-351, 1995.
77. Gullion, C.M.; Devous, M.D.; and Rush, A.J. Effects of four normalizing methods on data analytic results in functional brain imaging. Biological Psychiatry, 40:1106-1121, 1996.
78. Gur, R.E.; Gur, R.C.; Skolnick, B.E.; Caroff, S.; Obrist, W.D.; Resnick, S.; and Reivich, S. Brain function in psychiatric disorders. Archives of General Psychiatry, 42:329-334, 1985.
79. Gur, R.E.; Jaggi, J.L.; Shtasel, D.L.; Ragland, D.; and Gur, R.C. Cerebral blood flow in schizophrenia: Effects of memory processing and regional activation. Biological Psychiatry, 35:3-15, 1994.
80. Gur, R.E.; Mozley, P.D.; Resnick, S.M.; Mozley, L.H.; Shtasel, D.L.; Gallacher, F.; Arnold, S.E.; Karp, J.S.; Alavi, A.; Reivich, M.; and Gur, R.C. Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features. Archives of General Psychiatry, 52:657-667, 1995.
81. Gur, R.E.; Resnick, S.M.; Alavi, A.; Gur, R.C.; Caroff, S.; Dann, R.; Silver, F.L.; Saykin, A.J.; Chawluk, J.B.; Kushner, M.; and Reivich, M. Regional brain function in schizophrenia: I. A positron emission tomography study. Archives of General Psychiatry, 44:119-125, 1987.
82. Gur, R.E.; Resnick, S.M.; and Gur, R.C. Laterality and frontality of cerebral blood flow metabolism in schizophrenia: Relationship to symptom specificity. Psychiatry Research, 27:325-334, 1989.
83. Hawton, K.; Shepstone, B.; Soper, N.; and Reznek, L. Single-photon emission computerised tomography (SPECT) in schizophrenia. British Journal of Psychiatry, 156:425-427, 1990.
84. Hazlett, E.A.; Buchsbaum, M.S.; Haznedar, M.M.; Singer, M.B.; Schnur, D.B.; Jimenez, E.A.; Buchsbaum, B.R.; and Troyer, B.T. Prefrontal cortex glucose metabolism and startle eyeblink modification abnormalities in unmedicated schizophrenia patients. Psychophysiology, 35:186-198, 1998.
85. Haznedar, M.M.; Buchsbaum, M.S.; Luu, C.; Hazlett, E.A.; Siegel, B.V., Jr.; Lohr, J.; Wu, J.; Haier, R.J.; and Bunney, W.E., Jr. Anterior cingulate gyrus metabolic rate decreased in schizophrenia. American Journal of Psychiatry, 154:682-684, 1997.
86. Heaton, R.K. Wisconsin Card Sorting Test Manual. Odessa, FL: Psychological Assessment Resources, 1981.
87. Hertz, L., and Peng, L. Energy metabolism at the cellular level of the CNS. Canadian Journal of Physiology and Pharmacology, 70(Suppl.):145-157, 1992.
88. Holcomb, H.H.; Cascella, N.G.; Medoff, D.R.; Gastineau, E.A.; Loats, H.; Thaker, G.K.; Conley, R.R.; Dannals, R.F.; Wagner, H.N.; and Tamminga, C.A. PET-FDG test-retest reliability during a visual discrimination task in schizophrenia. Journal of Computer Assisted Tomography, 17:704-709, 1993.
89. Holcomb, H.H.; Cascella, N.G.; Thaker, G.K.; Medoff, D.R.; Dannals, R.F.; and Tamminga, C.A. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. American Journal of Psychiatry, 153:41-49, 1996.
90. Horwitz, B. Simulating functional interactions in the brain: A model for examining correlations between regional cerebral metabolic rates. International Journal of Bio-medical Computing, 26:149-170, 1990.
91. Horwitz, B.; Swedo, S.E.; Grady, C.L.; Pietrini, P.; Schapiro, M.B.; Rapoport, J.L.; and Rapoport, S.I. Cerebral metabolic pattern in obsessive-compulsive disorder: Altered intercorrelations between regional rates of glucose utilization. Psychiatry Research: Neuroimaging, 40:221-237, 1991.
92. Hyttel, J.; Larsen, J.-J.; Christensen, A.V.; and Arnt, J. Receptor binding profiles of neuroleptics. Psychopharmacology, 2(Suppl.):9-16, 1985.
93. Ingvar, D.H., and Franzén, G. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatrica Scandinavica, 50:425-462, 1974.
94. Jacobsen, L.K.; Hamburger, S.D.; Van Horn, J.D.; Vaituzis, A.C.; McKenna, K.; Frazier, J.A.; Gordon, C.T.; Lenane, M.C.; Rapoport, J.L.; and Zametkin, A.J. Cerebral glucose metabolism in childhood onset schizophrenia. Psychiatry Research: Neuroimaging, 75:131-144, 1997.
95. Jernigan, T.L.; Sargent, T. III; Pfefferbaum, A.; Kusubov, N.; and Stahl, S.M. 18-Fluorodeoxyglucose PET in schizophrenia. Psychiatry Research, 16:317-330, 1985.
96. Kato, T.; Shioiri, T.; Murashita, J.; Hamakawa, H.; Inubushi, T.; and Takahashi, S. Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia. Psychiatry Research: Neuroimaging, 61:151-160, 1995.
97. Katz, M.; Buchsbaum, M.S.; Siegel, B.V.; Wu, J.; Haier, R.J.; and Bunney, W.E., Jr. Correlational patterns of cerebral glucose metabolism in never-medicated schizophrenics. Neuropsychobiology, 33:1-11, 1996.
98. Kessler, R.M.; Clark, C.M.; Buchsbaum, M.S.; Holcomb, H.; Margolin, R.A.; Cappeletti, J.; Channing, M.; Manning, R.G.; van Kammen, D.P.; King, A.C.; and Johnson, J. Regional correlations in patterns of glucose use in patients with schizophrenia and normal subjects during mild pain stimulation. In: Heiss, W.D., and Phelps, M.D., eds. Positron Emission Tomography of the Brain. Berlin, Germany: Springer-Verlag, 1983. pp. 196-200.
99. Ketter, T.A.; George, M.S.; Kimbrell, T.A.; Benson, E.; and Post, R.M. Functional brain imaging, limbic function, and affective disorders. The Neuroscientist, 2:55-65, 1996.
100. 11C-glucose positron emission tomography. Psychiatry Research, 21:285-292, 1987.
101. Kling, A.S.; Metter, E.J.; Riege, W.H.; and Kuhl, D.E. Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression. American Journal of Psychiatry, 143:175-180, 1986.
102. Mallet, L.; Mazoyer, B.; and Martinot, J.-L. Functional connectivity in depressive, obsessive-compulsive, and schizophrenic disorders: An exploratory correlational analysis of regional cerebral metabolism. Psychiatry Research: Neuroimaging, 82:83-93, 1998.
103. Mega, M.S., and Cummings, J.L. Frontal-subcortical circuits and neuropsychiatric disorders. Journal of Neuropsychiatry and Clinical Neurosciences, 6:358-370, 1994.
104. Metter, J.; Riege, W.H.; Hanson, W.R.; Jackson, C.A.; Kempler, D.; and Lancker, D.V. Subcortical structures in aphasia: An analysis based on (F-18)-fluorodeoxyglucose, positron emission tomography, and computed tomography. Archives of Neurology, 45:1229-1234, 1988.
105. 3 antagonist ondansetron: A 2-deoxyglucose autoradiographic study in the rat. Brain Research, 538:289-294, 1991.
106. Mozley, L.H.; Gur, R.C.; Gur, R.E.; Mozley, P.D.; and Alavi, A. Relationships between verbal memory performance and the cerebral distribution of fluorodeoxyglucose in patients with schizophrenia. Biological Psychiatry, 40:443-451, 1996.
107. Nuechterlein, K.H.; Parasuraman, R.; and Jiang, Q. Visual sustained attention: Image degradation produces rapid decrement overtime. Science, 220:327-329, 1983.
108. Overall, J.E., and Gorham, D.R. The Brief Psychiatric Rating Scale. Psychological Reports, 10:799-812, 1962.
109. Pahl, J.J.; Mazziotta, J.C.; Bartzokis, G.; Cummings, J.; Altschuler, L.; Mintz, J.; Marder, S.R.; and Phelps, M.E. Positron-emission tomography in tardive dyskinesia. Journal of Neuropsychiatry and Clinical Neurosciences, 7:457-465, 1995.
110. Pantelis, C.; Barnes, T.R.E.; and Nelson, H.E. Is the concept of frontal-subcortical dementia relevant to schizophrenia? British Journal of Psychiatry, 160:442-460, 1992.
111. Parellada, E.; Catafau, A.M.; Benardo, M.; Lomeña, F.; Gonzalez-Monclús, E.; and Setoain, J. Prefrontal dysfunction in young acute neuroleptic-naive schizophrenic patients: A resting activation SPECT study. Psychiatry Research: Neuroimaging, 55:131-139, 1994.
112. Paulman, R.G.; Devous, M.D.; Gregory, R.R.; Herman, J.H.; Jennings, L.; Bonte, F.J.; Nasrallah, H.A.; and Raese, J.D. Hypofrontality and cognitive impairment in schizophrenia: Dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function. Biological Psychiatry, 27:377-399, 1990.
113. Penney, J.B., and Young, A.B. Speculations on the functional anatomy of basal ganglia dysfunction. Annual Review of Neuroscience, 6:73-94, 1983.
114. Pettegrew, J.W.; Keshavan, M.S.; Panchalingam, K.; Strychor, S.; Kaplan, D.B.; Tretta, M.G.; and Allen, M. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first episode, drug-naive schizophrenics. Archives of General Psychiatry, 48:563-568, 1991.
115. Phelps, M.E.; Huang, S.C.; Hoffman, E.F.; Hoffman, E.J.; Selin, C.; Sokoloff, L.; and Kuhl, D.E. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method. Annals of Neurology, 6:371-388, 1979.
116. Potkin, S.G.; Buchsbaum, M.S.; Jin, Y.; Tang, C.; Telford, J.; Friedman, G.; Lottenberg, S.; Najafi, A.; Culasekaram, B.; Costa, J.; Richmond, G.H.; and Bunney, W.E., Jr. Clozapine effects on glucose metabolic rate in striatum and frontal cortex. Journal of Clinical Psychiatry, 55(Suppl. B):63-66, 1994.
117. Raven, J.C.; Court, J.H.; and Raven, J. Manual for Raven's Progressive Matrices and Vocabulary Scales. London, England: H.K. Lewis, 1983.
118. Resnick, S.M.; Gur, R.E.; Alavi, A.; Gur, R.C.; and Reivich, M. Positron emission tomography and subcortical glucose metabolism in schizophrenia. Psychiatry Research, 24:1-11, 1988.
119. Rezai, K.; Andreasen, N.C.; Alliger, R.; Cohen, G.; Swayze, V. II; and O'Leary, D.S. The neuropsychology of the prefrontal cortex. Archives of Neurology, 50:636-642, 1993.
120. Roland, P.E. Somatotopical tuning of postcentral gyms during focal attention in man: A regional cerebral blood flow study. Journal of Neurophysiology, 46:744-754, 1981.
121. Ross, D.E.; Thaker, G.K.; Holcomb, H.H.; Cascella, N.G.; Medoff, D.R.; and Tamminga, C.A. Abnormal smooth pursuit eye movements in schizophrenic patients are associated with cerebral glucose metabolism in oculomotor regions. Psychiatry Research, 58:53-67, 1995.
122. Rubin, P.; Holm, S.; Madsen, P.L.; Friberg, L.; Videbech, P.; Andersen, H.S.; Bendsen, B.B.; Stromso, N.; Larsen, J.L.; Lassen, N.A.; and Hemmingsen, R. Regional cerebral blood flow distribution in newly diagnosed schizophrenia and schizophreniform disorder. Psychiatry Research, 53:57-75, 1994.
123. Sagawa, K.; Kawakatsu, S.; Shibuya, I.; Oiji, A.; Morinobu, S.; Komatani, A.; Yazaki, M.; and Totsuka, S. Correlation of regional cerebral blood flow with performance on neuropsychological tests in schizophrenic patients. Schizophrenia Research, 3:241-246, 1990.
124. 133xenon clearance study. Psychiatry Research, 52:215-236, 1994.
125. Schneider, F.; Gur, R.E.; Mozley, L.H.; Smith, R.J.; Mozley, D.P.; Censits, D.M.; Alavi, A.; and Gur, R.C. Mood effects on limbic blood flow correlate with emotional self-rating: A PET study with oxygen-15 labeled water. Psychiatry Research: Neuroimaging, 61:265-283, 1995.
126. Schröder, J.; Buchsbaum, M.S.; Siegel, B.V.; Geider, F.J.; Haier, R.J.; Lohr, J.; Wu, J.; and Potkin, S.G. Patterns of cortical activity in schizophrenia. Psychological Medicine, 24:947-955, 1994.
127. Schröder, J.; Buchsbaum, M.S.; Siegel, B.V.; Geider, F.J.; Lohr, J.; Tang, C.; Wu, J.; and Potkin, S.G. Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia. Schizophrenia Research, 19:41-53, 1996.
128. Schröder, J.; Buchsbaum, M.S.; Siegel, B.V.; Geider, F.J.; and Niethammer, R. Structural and functional correlates of subsyndromes in chronic schizophrenia. Psychopathology, 28:38-45, 1995.
129. 15O-positron emission tomographic scanning in predominantly never-treated acute schizophrenic patients. Lancet, 11:1448-1452, 1983.
130. Shihabuddin, L.; Buchsbaum, M.S.; Hazlett, E.A.; Haznedar, M.M.; Harvey, P.D.; Newman, A.; Schnur, D.B.; Spiegel-Cohen, J.; Wei, T.; Machac, J.; Knesaurek, K.; Vallabhojosula, S.; Singer, M.B.; Ciaravolo, T.M.; and Luu-Hsia, C. Dorsal striatal size, shape, and metabolic rate in neuroleptic-naive and previously medicated schizophrenic patients performing a verbal learning task. Archives of General Psychiatry, 55:235-243, 1998.
131. Shioiri, T.; Kato, T.; Inubushi, T.; Murashita, J.; and Takahashi, S. Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia. Psychiatry Research: Neuroimaging, 55:223-235, 1994.
132. Siegel, B.V.; Buchsbaum, M.S.; Bunney, W.E., Jr.; Gottschalk, L.A.; Haier, R.J.; Lohr, J.B.; Lottenberg, S.; Najafi, A.; Nuechterlein, K.H.; Potkin, S.G.; and Wu, J.C. Cortico-striatal-thalamic circuits and brain glucose metabolic activity in 79 unmedicated male schizophrenics. American Journal of Psychiatry, 150:1325-1336, 1993.
133. Siegel, B.V.; Nuechterlein, K.H.; Abel, L.; Wu, J.C.; and Buchsbaum, M.S. Glucose metabolic correlates of continuous performance test performance in adults with a history of infantile autism, schizophrenics, and controls. Schizophrenia Research, 17:85-94, 1995.
134. Silbersweig, D.A.; Stem, E.; Frith, C.; Cahill, C.; Holmes, A.; Grootoonk, S.; Seaward, J.; McKenna, P.; Chua, S.E.; Schnorr, L.; Jones, T.; and Frackowiak, R.S.J. A functional neuroanatomy of hallucinations in schizophrenia. Nature, 378:176-179, 1995.
135. 14C deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat. Journal of Neurochemistry, 28:897-916, 1977.
136. Swerdlow, N.R., and Koob, G.F. Dopamine, schizophrenia, mania, and depression: Toward a unified hypothesis of cortico-striato-pallido-thalamic function. Behavioral and Brain Sciences, 10:197-245, 1987.
137. Swerdlow, N.R., and Koob, G.F. Authors' response. Behavioral and Brain Sciences, 13:172-175, 1990.
138. Szabo, Z.; Camargo, E.E.; Sostre, S.; Shafique, I.; Sadzot, B.; Links, J.M.; Dannals, R.F.; and Wagner, H.N. Factor analysis of regional cerebral glucose metabolic rates in healthy men. European Journal of Nuclear Medicine, 19:469-475, 1992.
139. Szechtman, H.J.; Nahmais, C.; Garnett, E.S.; Firnau, G.; Brown, G.; Kaplan, R.; and Cleghorn, J. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia. Archives of General Psychiatry, 45:523-532, 1988.
140. Szymanski, S.; Gur, R.C.; Gallacher, F.; Mozley, L.H.; and Gur, R.E. Vulnerability to tardive dyskinesia development in schizophrenia: An FDG-PET study of cerebral metabolism. Neuropsychopharmacology, 15:567-575, 1996.
141. Tamminga, C.A.; Burrows, G.H.; Chase, T.N.; Alphs, L.D.; and Thaker, G.K. Dopamine neuronal tracts in schizophrenia: Their pharmacology and in vivo glucose metabolism. Annals of the New York Academy of Sciences, 537:443-450, 1988.
142. Tamminga, C.A.; Thaker, G.K.; Buchanan, R.; Kirkpatrick, B.; Alphs, L.; Chase, T.; and Carpenter, W.T., Jr. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Archives of General Psychiatry, 49:522-530, 1992.
143. Vita, A.; Bressi, S.; Perani, D.; Invernizzi, G.; Giobbio, G.M.; Massimiliano, D.; Garbarini, M.; Sole, A.D.; and Fazio, F. High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients. American Journal of Psychiatry, 152:876-882, 1995.
144. Volkow, N.D.; Brodie, J.D.; Wolf, A.P.; Angrist, B.; Russell, J.; and Cancro, R. Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration. Journal of Neurology, Neurosurgery and Psychiatry, 49:1190-1202, 1986.
145. Volkow, N.D.; Wolf, A.P.; Brodie, J.D.; Cancro, R.; Overall, J.E.; Rhoades, H.; and Van Gelder, P. Brain interactions in chronic schizophrenics under resting and activation conditions. Schizophrenia Research, 1:47-53, 1988.
146. Volkow, N.D.; Wolf, A.P.; Van Gelder, P.; Brodie, J.D.; Overall, J.E.; Cancro, R.; and Gomez-Mont, F. Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia. American Journal of Psychiatry, 144:151-157, 1987.
147. Warkentin, S.; Nilsson, A.; Risberg, J.; Karlson, S.; Flekköy, K.; Franzén, G.; Gustafson, L.; and Rodriguez, G. Regional cerebral blood flow in schizophrenia: Repeated studies during a psychotic episode. Psychiatry Research: Neuroimaging, 35:27-38, 1990.
148. Weinberger, D.R. A connectionist approach to the prefrontal cortex. Journal of Neuropsychiatry and Clinical Neurosciences, 5:241-253, 1993.
149. Weinberger, D.R., and Berman, K.F. Speculation on the meaning of cerebral metabolic hypofrontality in schizophrenia. Schizophrenia Bulletin, 14(2):157-168, 1988.
150. Weinberger, D.R.; Berman, K.F.; and Zec, R.F. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenics: I. Regional cerebral blood flow evidence. Archives of General Psychiatry, 43:114-124, 1986.
151. Wiesel, F.A.; Blomqvist, G.; Greitz, T.; Nyman, H.; Schalling, D.; Stone-Elander, S.; Widen, L.; and Wik, G. Regional brain glucose metabolism in neuroleptic-free schizophrenic patients in an acute phase of the disease. In: Shagass, C.; Josiassen, R.C.; Bridger, W.H.; Weiss, K.J.; Stoff, D.; and Simpson, G.M., eds. Biological Psychiatry 1985: Proceedings of the Fourth World Congress of Biological Psychiatry. New York, NY: Elsevier Science Publishing Company, 1985. pp. 392-394.
152. Wiesel, F.A.; Wik, G.; Sjögren, I.; Blomqvist, G.; and Greitz, T. Altered relationships between metabolic rates of glucose in brain regions of schizophrenic patients. Acta Psychiatrica Scandinavica, 76:642-647, 1987a.
153. Wiesel, F.A.; Wik, G.; Sjögren, I.; Blomqvist, G.; Greitz, T.; and Stone-Elander, S. Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates. Acta Psychiatrica Scandinavica, 76:628-641, 1987b.
154. Wik, G.; Wiesel, F.A.; Sjögren, I.; Blomqvist, G.; Greitz, T.; and Stone-Elander, S. Effects of sulpiride and chlorpromazine on regional cerebral glucose metabolism in schizophrenic patients as determined by emission tomography. Psychopharmacology, 97:309-318, 1989.
155. Williamson, P. Hypofrontality in schizophrenia: A review of the evidence. Canadian Journal of Psychiatry, 32:399-404, 1987.
156. Williamson, P.; Drost, D.; Stanley, J.; Carr, T.; Morrison, S.; and Merskey, H. Localized phosphorus-31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls. [Letter] Archives of General Psychiatry, 48:578, 1991.
157. Wolkin, A.; Angrist, B.; Wolf, A.; Brodie, J.D.; Wolkin, B.; Jaeger, J.; Cancro, R.; and Rotrosen, J. Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography. Psychopharmacology, 92:241-246, 1987.
158. Wolkin, A.; Angrist, B.; Wolf, A.; Brodie, J.D.; Wolkin, B.; Jaeger, J.; Cancro, R.; and Rotrosen, J. Low frontal glucose utilization in chronic schizophrenia: A replication study. American Journal of Psychiatry, 145:251-253, 1988.
159. Wolkin, A.; Jaeger, J.; Brodie, J.D.; Wolf, A.P.; Fowler, J.; Rotrosen, J.; Gomez-Mont, F.; and Cancro, R. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. American Journal of Psychiatry, 142:564-571, 1985.
160. Wolkin, A.; Sanfilipo, M.; Angrist, B.; Duncan, E.; Wieland, S.; Wolf, A.P.; Brodie, J.D.; Cooper, T.B.; Laska, E.; and Rotrosen, J.P. Acute d-amphetamine challenge in schizophrenia: Effects on cerebral glucose utilization and clinical symptomatology. Biological Psychiatry, 36:317-325, 1994.
161. Wolkin, A.; Sanfilipo, M.; Duncan, E.; Angrist, B.; Wolf, A.P.; Cooper, T.B.; Brodie, J.D.; Laska, E.; and Rotrosen, J.P. Blunted change in cerebral glucose utilization after haloperidol treatment in schizophrenic patients with prominent negative symptoms. American Journal of Psychiatry, 153:346-354, 1996.
162. Wolkin, A.; Sanfilipo, M.; Wolf, A.P.; Angrist, B.; Brodie, J.D.; and Rotrosen, J. Negative symptoms and hypofrontality in chronic schizophrenia. Archives of General Psychiatry, 49:959-965, 1992.
163. Wong, M.T.H.; Fenwick, P.B.C.; Lumsden, J.; Fenton, G.W.; Maisey, M.N.; Lewis, P.; and Badawi, R. Positron emission tomography in male violent offenders with schizophrenia. Psychiatry Research: Neuroimaging, 68:111-123, 1997.
164. Wu, J.C.; Siegel, B.V.; Haier, R.J.; and Buchsbaum, M.S. Testing the Swerdlow/Koob model of schizophrenia pathophysiology using positron emission tomography. Behavioral and Brain Sciences, 13:169-170, 1990.